Literature DB >> 24750363

Long-term stimulation of Toll-like receptor 3 in primary human hepatocytes leads to sensitization for antiviral responses induced by poly I:C treatment.

R Broering1, M Lutterbeck, M Trippler, K Kleinehr, L Poggenpohl, A Paul, G Gerken, J F Schlaak.   

Abstract

Chronic hepatitis C infection is associated with increased expression of interferon-sensitive genes (ISGs) in the liver, which is, paradoxically, correlated with the nonresponse to interferon (IFN)-based therapies. In the present study PHHs were isolated from HCV-infected or uninfected patients and stimulated with the TLR1-9 ligands for 6-24 h. Expression of cytokines and ISGs was determined by ELISA and qRT-PCR. A comparative analysis was performed for TLR3 signalling, which was also correlated with single nucleotide polymorphisms (SNPs) related to HCV pathogenesis. TLR-activated PHHs produced pro-inflammatory and anti-inflammatory cytokines, whereas IFNs were exclusively induced by TLR3 stimulation. Here, IL-29 and IL-28A were significantly highly expressed than IFN-α and IFN-β. TLR3-induced IFN response was enhanced in hepatocytes isolated from patients with HCV infection. This hyper-responsiveness could be mimicked in naïve PHHs consistently stimulated with low dose of poly I:C, but not Guardiquimod. The higher responsiveness in PHH isolated from HCV-infected patients could be partially explained by higher frequencies of unfavourable SNP alleles of different SNPs associated with HCV progression and treatment outcome. These data suggest that durable activation of TLR3 but not TLR7, by low doses of viral replicative intermediates, increases the sensitivity to viral invasion. These findings shed new light on the relevance of TLR3 in the pathogenesis of HCV and may provide a possible explanation for the increased ISG expression during chronic HCV infection, the so-called IFN paradox.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  Toll-like receptors; hepatitis C virus; interleukin-28A/B; interleukin-29; primary human hepatocytes

Mesh:

Substances:

Year:  2013        PMID: 24750363     DOI: 10.1111/jvh.12174

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  11 in total

1.  Nucleic acid-based polymers effective against hepatitis B Virus infection in patients don't harbor immunostimulatory properties in primary isolated liver cells.

Authors:  Catherine Isabell Real; Melanie Werner; Andreas Paul; Guido Gerken; Joerg Friedrich Schlaak; Andrew Vaillant; Ruth Broering
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

2.  TLR5 activation in hepatocytes alleviates the functional suppression of intrahepatic CD8+ T cells.

Authors:  Hu Yan; Maohua Zhong; Jingyi Yang; Jiabao Guo; Jie Yu; Yi Yang; Zhiyong Ma; Bali Zhao; Yue Zhang; Junzhong Wang; Chunchen Wu; Ulf Dittmer; Dongliang Yang; Mengji Lu; Ejuan Zhang; Huimin Yan
Journal:  Immunology       Date:  2020-10-12       Impact factor: 7.397

3.  Interferon β (IFN-β) Production during the Double-stranded RNA (dsRNA) Response in Hepatocytes Involves Coordinated and Feedforward Signaling through Toll-like Receptor 3 (TLR3), RNA-dependent Protein Kinase (PKR), Inducible Nitric Oxide Synthase (iNOS), and Src Protein.

Authors:  Liyong Zhang; Wenpei Xiang; Guoliang Wang; Zhengzheng Yan; Zhaowei Zhu; Zhong Guo; Rajib Sengupta; Alex F Chen; Patricia A Loughran; Ben Lu; Qingde Wang; Timothy R Billiar
Journal:  J Biol Chem       Date:  2016-05-17       Impact factor: 5.157

4.  TLR3 Plays Significant Roles against HBV-Associated HCC.

Authors:  Xiao-Lan Chen; Yu-Yin Xu; Li Chen; Gui-Lan Wang; Yin Shen
Journal:  Gastroenterol Res Pract       Date:  2015-04-23       Impact factor: 2.260

5.  Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control during Antiviral Therapy.

Authors:  Chao Liu; Xuan Huang; Melanie Werner; Ruth Broering; Jun Ge; Yongyin Li; Baolin Liao; Jian Sun; Jie Peng; Mengji Lu; Jinlin Hou; Xiaoyong Zhang
Journal:  Front Immunol       Date:  2017-03-23       Impact factor: 7.561

6.  Controversial: Early Innate Responses to Hepatitis B Virus Infection, an Explanation for Viral Persistence?

Authors:  Ruth Broering; Xufeng Luo; Jia Liu; Mengji Lu
Journal:  Virol Sin       Date:  2020-07-06       Impact factor: 4.327

7.  All-In-One: Advanced preparation of Human Parenchymal and Non-Parenchymal Liver Cells.

Authors:  Melanie Werner; Sabrina Driftmann; Kathrin Kleinehr; Gernot M Kaiser; Zotlan Mathé; Juergen-Walter Treckmann; Andreas Paul; Kathrin Skibbe; Joerg Timm; Ali Canbay; Guido Gerken; Joerg F Schlaak; Ruth Broering
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

8.  Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.

Authors:  Faseeha Noordeen; Catherine A Scougall; Arend Grosse; Qiao Qiao; Behzad B Ajilian; Georget Reaiche-Miller; John Finnie; Melanie Werner; Ruth Broering; Joerg F Schlaak; Andrew Vaillant; Allison R Jilbert
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

9.  Human PSC-Derived Hepatocytes Express Low Levels of Viral Pathogen Recognition Receptors, but Are Capable of Mounting an Effective Innate Immune Response.

Authors:  Lena Fischer; Baltasar Lucendo-Villarin; David C Hay; Cliona O'Farrelly
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

10.  Intrahepatic TLR3 and IFNL3 Expressions Are Associated with Stages of Fibrosis in Chronic Hepatitis C.

Authors:  Keyla Santos Guedes de Sá; Ednelza da Silva Graça Amoras; Simone Regina Souza da Silva Conde; Maria Alice Freitas Queiroz; Izaura Maria Vieira Cayres-Vallinoto; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.